Program Book - Confex

ACR/ARHP Poster Session B
Medical Center, Section of Dermatology, Tokyo, Japan, 6 St.
Luke’s International Hospital, Department of Dermatology,
Tokyo, Japan, 7 Japan
1411. SLE and Sickle Cell Disease (SCD) As Comorbid Conditions.
Asha Thomas, Madhu Kalyan Pendurthi, Robert W.
McMurray and Vikas Majithia, University of Mississippi
Medical Center, Jackson, MS
1412. Ultrasonographic Evaluation of Hand and Wrist in Systemic
Lupus Erythematosus without Arthralgia. Hosung Yoon, The
Catholic University, Incheon, South Korea
1413. Pregnancy Outcomes and Fetal Complications in Patients
with Systemic Lupus Erythematosus:a Retrospective
Analysis in Korea. Eun-Jung Park 1 , Jiwon Hwang 1 , Jaejoon
Lee 2 , Joong Kyong Ahn 3 , Chan Hong Jeon 4 , Hoon-Suk Cha 1
and Eun-Mi Koh 1 , 1 Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, South Korea,
2
Samsung Medical Center, Sunkyunkwan University School
of Medicine, Seoul, South Korea, 3 Kangbuk Samsung
hospital, Sungkyunkwan University School of Medicine,
Seoul, South Korea, 4 Soonchunhyang University College of
Medicine, Bucheon, South Korea
1414. Relationship Between Age of Onset and Clinical Profile
In Systemic Lupus Erythematosus Patients. Julia
Martínez-Barrio, Juan G. Ovalles, Francisco J. López-Longo,
Inmaculada de la Torre, Lina Martínez-Estupiñán, Juan C.
Nieto and Luis Carreño, Gregorio Marañón Hospital, Madrid,
Spain
1415. Serum Cystatin C Is Affected by Inflammation and
Renal Dysfunction in Patients with Systemic Lupus
Erythematosus. Christine LY Chew 1 , Awal Al-M Husain 1 ,
Philip Pemberton 2 , Sahena Haque 1 , Allen Yates 2 and Ian
N. Bruce 3 , 1 University of Manchester, Manchester, United
Kingdom, 2 Manchester Royal Infirmary, Manchester, United
Kingdom, 3 A, Manchester, United Kingdom
1416. Factors Associated with Belimumab Treatment Benefit:
Results From Phase 3 Studies in Patients with Systemic
Lupus Erythematosus. R.F. van Vollenhoven 1 , M. Petri 2 , R.
Cervera 3 , C. Kleoudis 4 , Z.J. Zhong 5 , D. Roth 6 , W. Freimuth 5
and BLISS-5 2 and BLISS-76 Study Groups 7 , 1 The Karolinska
Institute, Stockholm, Sweden, 2 Johns Hopkins University
School of Medicine, Baltimore, MD, 3 Hospital Clinic,
Barcelona, Spain, 4 GlaxoSmithKline, Durham, NC, 5 Human
Genome Sciences, Inc., Rockville, MD, 6 GlaxoSmithKline,
King of Prussia, PA, 7 Multicenter
1417. Towards a Quantitative Assessment of Renal Biopsies
for Lupus Nephritis. Siddharth S. Samsi 1 , Brad H. Rovin 2 ,
Sara Cole 3 , Don Stredney 1 and Wael N. Jarjour 4 , 1 Ohio
Supercomputer Center, Columbus, OH, 2 Ohio State
University Medical Center, Columbus, OH, 3 The Ohio State
University, Columbus, OH, 4 Ohio State University, Columbus,
OH
1418. The Relationship Between Pain Coping Skills and Pain,
Fatigue, Mood, and Lupus Activity. Preethi Kurakula,
Tamara J. Somers, Lisa G. Criscione-Schreiber, Francis J.
Keefe and Megan E. B. Clowse, Duke University Medical
Center, Durham, NC
1419. Memory Complaints in Lupus Patients: Relationship to
Lupus Activity, Symptoms, Quality of Life, Psychological
Distress, and Coping. Megan E. B. Clowse 1 , Lisa G. Criscione-
Schreiber 1 , Meenakshi Jolly 2 , Francis J. Keefe 1 and Tamara
J. Somers 1 , 1 Duke University Medical Center, Durham, NC,
2
Rush University Medical Center, Chicago, IL
1420. The Leiden Neuropsychiatric Systemic Lupus
Erythematosus Clinic; Establishing Clinical Phenotypes. E.
Zirkzee, G. Steup-Beekman, H. Middelkoop, E. Bollen, N.
Van der Wee, E. Baptist, R. Van der Mast, M. Huisman, J.
Luyendijk, M. Van Buchem and T. Huizinga, Leiden University
Medical Center, Leiden, Netherlands
1421. Limited Value of Soluble Urokinase Plasminogen Activator
Receptor As a Disease Activity Marker in Patients with
Systemic Lupus Erythematosus. Helena Enocsson, Jonas
Wettero, Thomas Skogh and Christopher Sjowall, Linkoping
University, Linkoping, Sweden
1422. Caregiver Burden Is Associated with Worse Dyadic
Relationship and Health Outcomes in Lupus. Amita Thakkar,
Rachel A. Mikolaitis, Joel A. Block and Meenakshi Jolly, Rush
University Medical Center, Chicago, IL
Systemic Lupus Erythematosus - Human Etiology and
Pathogenesis II: Innate Immune System and Organ Damage
1423. Genetic Ancestry, Serum Interferon-α Activity and
Autoantibodies in Systemic Lupus Erythematosus. Kichul
Ko, Beverly S. Franek and Timothy B. Niewold, University of
Chicago, Chicago, IL
1424. Analysis of Longitudinal Gene and Protein Expression
Data Classifies SLE Patients Based on Molecular Profiles
Associated with Disease Activity, Serology and Specific
Organ Manifestations. Mikhail Olferiev 1 , Kyriakos A. Kirou 2 ,
Dorthe Lundsgaard 3 , Klaus S. Frederiksen 3 , Jan Fleckner 3 and
Mary K. Crow 1 , 1 Mary Kirkland Center for Lupus Research,
Hospital for Special Surgery, New York, NY, 2 Mary Kirkland
Center for Lupus Care, Hospital for Special Surgery, New
York, NY, 3 NovoNordisk, Copenhagen, Denmark
1425. Estrogen Stimulation of Endosomal Toll-Like Receptor
Expression Lowers the Threshold of Activation in
Peripheral Blood Mononuclear Cells and Contributes to the
Gender Bias of Systemic Lupus Erythematosus. Nicholas
A. Young, Alexandra Friedman, Benjamin Kaffenberger and
Wael N. Jarjour, The Ohio State University Medical Center,
Columbus, OH
1426. Genome-Wide Analyses of IRF1 and H4 Acetylation in
SLE Monocytes. Kathleen E. Sullivan 1 , Lihua Shi 1 , Li Song 1 ,
Michelle Petri 2 and Zhe Zhang 3 , 1 Children’s Hospital of
Philadelphia, Philadelphia, PA, 2 Johns Hopkins Hospital,
2011 Program Book 237